EMA updates guidances on treatment, prophylaxis for chemical and biological agents
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyEuropeEuropean Medicines Agency (EMA)Medical countermeasures (MCM)PharmaceuticalsProduct developmentQuality Assurance and ControlRegulatory Intelligence/PolicyResearch, Design and DevelopmentSubmission and registration